ANGPTL8 and Insulin resistance: These results are in concordance with that described in 2014 by Fenz et al., in morbid-obesity and insulin resistance individuals in which ANGPTL8/ betatrophin is unaltered, but it correlates significantly to atherogenic lipid profiles in high-risk cohorts [23].